Connors, Joseph M.
1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
6 papers on CoChatORCID 0000-0002-1361-7531
Most cited papers
- Verified
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment
Cited by 2,241
- Verified
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature
Lymphoma Diagnosis and TreatmentGenomics and Chromatin Dynamics
Cited by 1,614
- Verified
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Sehn, L. H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K. J., Shenkier, T., Sutherland, J., et al. (2007) · Blood
Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment
Cited by 1,473
- Verified
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentImmune cells in cancer
Cited by 1,262
- Verified
Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition
Ennishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., Bashashati, A., Saberi, S., Boyle, M., Meissner, B., et al. (2019) · Cancer Discovery
Lymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 318
- Verified
Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting
Sehn, L. H., Donaldson, J., Filewich, A., Fitzgerald, C., Gill, K. K., Runzer, N., Searle, B., Souliere, S., Spinelli, J. J., Sutherland, J., et al. (2007) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 100
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free